Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Flibanserin Versus Placebo in Women Taking a Selective Serotonin Reuptake Inhibitor or Norepinephrine Serotonin Reuptake Inhibitor With Decreased Sexual Desire

NCT01040208 is registered in ClinicalTrials.gov with Sprout Pharmaceuticals, Inc as lead sponsor.

NCT NCT01040208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01040208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Flibanserin Versus Placebo in Women Taking a Selective Serotonin Reuptake Inhibitor or Norepinephrine Serotonin Reuptake Inhibitor With Decreased Sexual Desire
Lead sponsor
Sprout Pharmaceuticals, Inc
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2010
Completion date
January 31, 2011
Enrollment
111 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

depression, sexual dysfunctions, psychological